Abstract:Background: Mismatch repair deficiency (dMMR) due to germline mutations in DNA repair genes including MLH1, MSH2, MSH6 and PMS2, or somatic aberrant silencing of MLH1, is a well-established feature for Lynch syndrome, a major type of hereditary colorectal cancer (CRC). The purpose of this study is to derive prevalence of germline MMR gene mutations in Chinese population with dMMR CRC. Methods: ColonCore panel is designed for simultaneous detection of microsatellite instabiligy (MSI) status of 22 regions and mutations in 38 CRC-related genes. Whole exons of the 38 genes were covered by the panel. The MSI phenotype detection method was a read-count-distribution-based approach. It utilized the coverage ratio of a specific set of repeat lengths as the main characteristic of each microsatellite locus, and categorized a locus as unstable if the coverage ratio was less than a given threshold. The MSI status of a sample was determined by the percentage of unstable loci in the given sample. Results: Among 1394 postsurgical CRC patients whose MMR status were detected by immunohistochemistry (IHC), 99 patients were dMMR, accounting for 7.1%. The concordance rate was 92.3% between MSI and IHC. Next, we investigated the germline mutation spectrum of dMMR patients. About 26.3% patients harbored pathogenic germline MMR gene mutations, with 13%, 6%, 5% and 2% of patients carrying pathogenic MLH1, MSH2, MSH6 and PMS2 mutations, respectively. Specially, about 30% pathogenic MLH1 mutation occured in splice region. Among patients with pathogenic MMR gene mutations, their first cancer was diagnosed ranging from 22 to 69 years old with median age at diagnosis was 50, and only 57% have a family history of ≥ 1 relative with Lynch syndrome related cancers. Furthermore, 3% harbored pathogenic mutations in other genes. Approximately, 17% of patients harbored MMR gene variants of unknown significance (VUS) and 26% harbored other VUS. The remaining 28% of patients had no pathogenic or VUS mutations from this panel. Conclusions: The prevalence rate of germline pathogenic mutations is 26% in dMMR CRC patients, accounting for 1.8% of all resectable CRC patients. Median age at diagnosis of Lynch syndrome related cancers is 50 years old and nearly 40% Lynch syndrome patients have no family history. Legal entity responsible for the study: Ying Yuan. Funding: Burning Rock Biotech. Disclosure: C. Liu: Burning Rock Biotech. All other authors have declared no conflicts of interest.

Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes

DNA Mismatch Repair Preferentially Protects Genes from Mutation.

Pathogenic variants in human DNA damage repair genes mostly arose in recent human history

Pathogenic variants in human DNA damage repair genes mostly arose after the latest human out-of-Africa migration

Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

The association between MLH1 -93 G>A polymorphism of DNA mismatch repair and cancer susceptibility: A meta-analysis

[Mutation of Human Mismatch Repair Genes in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Families].

Clinical Relevance of Pathogenic Germline Variants in Mismatch Repair Genes in Chinese Breast Cancer Patients

Mismatch repair gene pathogenic germline variants in a population-based cohort of breast cancer

Impact of DNA mismatch repair system alterations on human fertility and related treatments

Evolutionary Origin of Human PALB2 Germline Pathogenic Variants

The Prevalence of Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

The Origins And Early Evolution Of Dna Mismatch Repair Genesmultiple Horizontal Gene Transfers And Co-Evolution

Preferential Protection of Genetic Fidelity Within Open Chromatin by the Mismatch Repair Machinery

The Analysis for Identifying Large DNA Fragment Aberrations of MSH2 and MLH1 Genes from Familial Colorectal Cancer in China

Analysis Of Hmlh1 Missense Mutations In East Asian Patients With Suspected Hereditary Nonpolyposis Colorectal Cancer

Mouse models of DNA mismatch repair in cancer research

Germline variants of homology‐directed repair or mismatch repair genes in cervical cancer

Mismatch Repair (MMR) Gene Mutation Carriers Have Favorable Outcome in Colorectal and Endometrial Cancer: A Prospective Cohort Study

Mismatch Repair Gene Germline Mutations in Patients with Prostate Cancer.